Liang, Jiabin
Cheng, Lulu
Feng, Jie
Han, Zeping
Huang, Chen
Xie, Fangmei
Li, Yongsheng
Luo, Xun
Wang, Qingmei
He, Jinhua
Chen, Hanwei
Article History
Received: 21 March 2023
Accepted: 15 September 2023
First Online: 13 October 2023
Declarations
:
: All experimental protocols were approved by Guangzhou Forevergen Biosciences for Laboratory Animal Welfare and Ethical review board (IACUC-AEWC-F2211019), and performed in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, eighth edition, 2011). This study is reported in accordance with ARRIVE guidelines for animal experiments.
: Not applicable.
: The authors declare no competing interests.